(2H8)-4,4'-Bipyridine

Names

[ Name ]:
(2H8)-4,4'-Bipyridine

[Synonym ]:
4,4'-Bipyridine-d
ADENOSINE CYCLPHOSPHATE
(H)-4,4'-Bipyridine
Adenosin Cyclophosphate
4,4'-bipyridine-d8
CYCLIC AMP-3',5'
adenosine-3',5'-cyclic-phosphate
adenosine 3',5'-cyclic monophosphate
3:5-CAMP
4,4'-bipyridyl
3',5'-CYCLIC AMP
Acrasin
CAMP

Biological Activity

[Description]:

4,4′-Dipyridyl-d8 is the deuterium labeled 4,4'-Dipyridyl[1].

[Related Catalog]:

Research Areas >> Others

Signaling Pathways >> Others >> Others

[In Vitro]

Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].

[References]

[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.

Chemical & Physical Properties

[ Density]:
1.1±0.1 g/cm3

[ Boiling Point ]:
304.8±0.0 °C at 760 mmHg

[ Melting Point ]:
111-114ºC(lit.)

[ Molecular Formula ]:
C₁₀D₈N₂

[ Molecular Weight ]:
164.233

[ Flash Point ]:
104.3±12.0 °C

[ Exact Mass ]:
164.118958

[ PSA ]:
25.78000

[ LogP ]:
1.20

[ Vapour Pressure ]:
0.0±0.6 mmHg at 25°C

[ Index of Refraction ]:
1.581

MSDS

Click to get detail MSDS

Safety Information

[ Symbol ]:

GHS06

[ Signal Word ]:
Danger

[ Hazard Statements ]:
H301-H315-H319-H335

[ Precautionary Statements ]:
P261-P301 + P310-P305 + P351 + P338

[ RIDADR ]:
UN 2811 6.1 / PGIII